Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024608
Filing Date
2024-10-03
Accepted
2024-10-03 16:15:09
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10032024_041004.html 4  
1 form4-10032024_041004.xml 4 7875
  Complete submission text file 0001415889-24-024608.txt   9281
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Walker Neal (Reporting) CIK: 0001604457 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 241351665